Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAge Labs (BIOA) Shares Outstanding (Weighted Average) (2024 - 2025)

BioAge Labs (BIOA) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $35.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 234.99% to $35.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $35.9 million through Dec 2025, up 234.99% year-over-year, with the annual reading at $35.9 million for FY2025, 234.99% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $35.9 million in Q4 2025 for BioAge Labs, roughly flat from $35.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $35.9 million in Q4 2025 to a low of $1.7 million in Q1 2024.